Miski, H.; Krupa, K.; Budzik, M.P.; Deptała, A.; Badowska-Kozakiewicz, A.
HER2-Positive Breast Cancer—Current Treatment Management and New Therapeutic Methods for Brain Metastasis. Biomedicines 2025, 13, 1153.
https://doi.org/10.3390/biomedicines13051153
AMA Style
Miski H, Krupa K, Budzik MP, Deptała A, Badowska-Kozakiewicz A.
HER2-Positive Breast Cancer—Current Treatment Management and New Therapeutic Methods for Brain Metastasis. Biomedicines. 2025; 13(5):1153.
https://doi.org/10.3390/biomedicines13051153
Chicago/Turabian Style
Miski, Hanna, Kamila Krupa, Michał Piotr Budzik, Andrzej Deptała, and Anna Badowska-Kozakiewicz.
2025. "HER2-Positive Breast Cancer—Current Treatment Management and New Therapeutic Methods for Brain Metastasis" Biomedicines 13, no. 5: 1153.
https://doi.org/10.3390/biomedicines13051153
APA Style
Miski, H., Krupa, K., Budzik, M. P., Deptała, A., & Badowska-Kozakiewicz, A.
(2025). HER2-Positive Breast Cancer—Current Treatment Management and New Therapeutic Methods for Brain Metastasis. Biomedicines, 13(5), 1153.
https://doi.org/10.3390/biomedicines13051153